Curious what people think about **UNH** going into earnings.
It feels like a lot of bad news is already out there (Medicare Advantage pressure, regulatory/DOJ noise, margins), but I can’t tell if the market thinks the worst is priced in or if there’s still downside risk.
For those following or holding:
* Are you staying in through earnings?
* Expecting clarity from guidance, or more uncertainty?
* Long-term hold for dividends, or trimming around earnings?
Would like to hear different perspectives.